What to know
Findings on SARS-CoV-2 surveillance and investigations
Helix, Inc., led a pilot study to demonstrate the utility of a nationwide viral surveillance program. This study centered on pan-respiratory genomes linked with key patient data and identified primary considerations and hurdles involved with developing this type of infrastructure.
The infrastructure standardized the process of patient consent, sample collection, and data reporting and returned data back to each site to ensure the analyses and decisions of each site were based on locally gathered information.
Awarded in 2022, this project was jointly supported by CDC's Office of AMD and the Center for Forecasting and Outbreak Analytics.
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.